Magnesium Chloride Injection is a sterile solution of Magnesium Chloride Hexahydrate in Water for Injection q.s. Each mL contains Magnesium Chloride Hexahydrate 200 mg, Sodium Chloride 9 mg, Benzyl Alcohol 1% as a preservative, Water for Injection, q.s. pH adjusted with Hydrochloric Acid and/or Sodium Hydroxide. Total osmolarity equivalent to 2.951 mOsm/mL.

Contains 1.97 mEq of Mg++ and Cl- per mL.

The structural formula is MgCl2•6H2O

Magnesium is the second most plentiful cation within cellular fluids. It is an important activator of many enzyme systems and deficits are accompanied by a variety of functional disturbances.

As an electrolyte replenisher in magnesium deficiencies.

Magnesium Chloride Injection should not be administered if there is renal impairment, marked myocardial disease or to comatose patients.

Do not use if a precipitate is present.

The usual precautions for parenteral administration should be observed. Administer with caution if flushing and sweating occurs. A preparation of a calcium salt should be readily available for intravenous injection to counteract potential serious signs of magnesium intoxication. As long as deep tendon reflexes are active it is probable that the patient will not develop respiratory paralysis. Respiration and blood pressure should be carefully observed during and after administration of Magnesium Chloride Injection.

Flushing, sweating, sharply lowered blood pressure, hypothermia, stupor and ultimately respiratory depression.

For intravenous infusion: 4 grams in 250 mL of 5% Dextrose Injection, at a rate not exceeding 3 mL per minute. Serum magnesium levels should serve as a guide to continued dosage.

1 to 40 grams daily.

Parenteral drug products should be inspected visually for particulate matter and discoloration prior to administration whenever solution and container permit.

Magnesium Chloride Injection 200 mg/mL (20% w/v).

NDC 67457-134-50
50 mL Multiple-Dose Vial. Individually boxed.

Store at 20° to 25°C (68° to 77°F). [See USP Controlled
Room Temperature.]

Manufactured for:
Mylan Institutional LLC
Morgantown, WV 26505

Manufactured by:
Mylan Institutional
Galway, Ireland

1084L101
Revised: 10/2021
MI:MAGNIJ:R4

NDC 67457-134-50     50 mL

Magnesium
Chloride
Injection

200 mg/mL
(20% w/v)

2.951 mOsm/mL

For Intravenous Use After
Dilution

Rx only Multiple-Dose Vial

Each mL contains: Magnesium
Chloride Hexahydrate 200 mg,
Sodium Chloride 9 mg, Benzyl
Alcohol 1% as a preservative,
Water for Injection q.s. pH adjusted
with Hydrochloric Acid and/or
Sodium Hydroxide.

Total osmolarity equivalent to
2.951 mOsm/mL.

Contains 1.97 mEq of Mg++ and CI¯
per mL.

WARNING: DO NOT USE IF A
PRECIPITATE IS PRESENT.

Store at 20° to 25°C (68° to 77°F).
[See USP Controlled Room
Temperature.]

Usual Dosage: See accompanying
prescribing information.

Manufactured for:
Mylan Institutional LLC
Morgantown, WV 26505 U.S.A.

Manufactured by:
Mylan Institutional
Galway, Ireland

MI:134:1C:R5

Mylan.com